Case number 2017-2354
Enzo Life Sciences, Inc. v. Gen-Probe Incorporated > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 26, 2019 | 99 | ORDER granting motion to dismiss 17-2354 and 17-2355 pursuant to FRAP 42(b) [98] filed by Appellant Enzo Life Sciences, Inc.; issuing mandate in 17-2354, 17-2355. The revised official caption for 17-2498, -2499, -2545, -2546 is reflected in the order. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [603130] [17-2354, 17-2355, 17-2498, 17-2499, 17-2545, 17-2546] [PBC] [Entered: 04/26/2019 09:47 AM] (3) |
| Apr 23, 2019 | 98 | MOTION of Appellant Enzo Life Sciences, Inc. to voluntarily dismiss appeal pursuant to FRAP 42(b). [Consent: unopposed]. Service: 04/23/2019 by email. [602424] [17-2354] [Justin Wilcox] [Entered: 04/23/2019 09:49 PM] (6) |
| Feb 13, 2019 | 97 | Amended Entry of appearance for Peter C. Magic as of counsel for Appellant Enzo Life Sciences, Inc.. Service: 02/13/2019 by email. [585730] [17-2354] [Peter Magic] [Entered: 02/13/2019 04:29 PM] (2) |
| Jan 7, 2019 | 96 | Submitted after ORAL ARGUMENT by Justin P.D. Wilcox for Enzo Life Sciences, Inc., Mr. John C. O'Quinn for Abbott Laboratories and Abbott Molecular, Inc. and Matthew Wolf for Becton Dickinson Diagnostics Inc., Becton Dickinson and Company, GeneOhm Sciences Inc., Hologic, Inc., Gen-Probe Incorporated, Roche Diagnostics Corporation, Roche Diagnostics Operations, INc., Roche Molecular Systems, Inc. and Roche NimbleGen, Inc. Panel: Judge: Prost , Judge: Reyna , Judge: Wallach. [576237] [JCP] [Entered: 01/07/2019 11:09 AM] (0) |
| Jan 3, 2019 | 95 | **TEXT ONLY** ORDER granting motion to withdraw attorney Michael P. Stadnick [94] filed by Appellant Enzo Life Sciences, Inc. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [575482] [JAB] [Entered: 01/03/2019 08:46 AM] (0) |
| Jan 2, 2019 | 94 | MOTION of Appellant Enzo Life Sciences, Inc. to withdraw counsel Michael P. Stadnick [Consent: unopposed]. Service: 01/02/2019 by email. [575429] [17-2354] [Michael Stadnick] [Entered: 01/02/2019 05:27 PM] (5) |
| Dec 17, 2018 | 93 | Response to notice of oral argument from the Appellant Enzo Life Sciences, Inc.. [572356] [17-2354] [Justin Wilcox] [Entered: 12/17/2018 04:29 PM] (3) |
| Dec 17, 2018 | 92 | Response to notice of oral argument from the Appellees Abbott Laboratories and Abbott Molecular, Inc.. [572076] [17-2354] [Jason Wilcox] [Entered: 12/17/2018 09:31 AM] (3) |
| Dec 17, 2018 | 91 | Response to notice of oral argument from the Appellees Abbott Laboratories, Abbott Molecular, Inc., Becton Dickinson Diagnostics Inc., Becton Dickinson and Company, Gen-Probe Incorporated, GeneOhm Sciences Inc., Hologic, Inc., Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., Roche Molecular Systems, Inc., Roche NimbleGen, Inc. [572053] [17-2354]--[Edited 12/17/2018 by JAB to correct filers] [Matthew Wolf] [Entered: 12/17/2018 08:51 AM] (3) |
| Dec 11, 2018 | 90 | Amended Entry of appearance for Michael P. Stadnick as of counsel for Appellant Enzo Life Sciences, Inc.. Service: 12/11/2018 by email. [571074] [17-2354] [Michael Stadnick] [Entered: 12/11/2018 10:05 PM] (2) |
| Dec 11, 2018 | 89 | Amended Entry of appearance for Justin P.D. Wilcox as principal counsel for Appellant Enzo Life Sciences, Inc.. Service: 12/11/2018 by email. [571073] [17-2354] [Justin Wilcox] [Entered: 12/11/2018 10:01 PM] (2) |
| Nov 19, 2018 | 88 | NOTICE OF ORAL ARGUMENT. Panel: 1901C. Case scheduled Jan 07, 2019 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 203. Response to Notice of Oral Argument due: 12/17/2018. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [566290] [JAB] [Entered: 11/19/2018 01:10 PM] (2) |
| Oct 11, 2018 | 87 | Notice from Appellees Abbott Laboratories and Abbott Molecular, Inc. regarding conflicts with oral argument (request not to schedule oral argument during the same week as Nos. 17-1240 & 18-1054 (companion cases) or 18-1053, 18-1376, or 18-1397). Service: 10/11/2018 by email. [556536] [17-2354] [John O'Quinn] [Entered: 10/11/2018 09:54 PM] (2) |
| Oct 3, 2018 | 86 | Notice from Appellees Gen-Probe Incorporated and Hologic, Inc. regarding conflicts with oral argument (December 3-7, 2018). Service: 10/03/2018 by email. [554631] [17-2354] [Matthew Wolf] [Entered: 10/03/2018 03:57 PM] (1) |
| Aug 8, 2018 | 85 | Notice from Appellees Gen-Probe Incorporated and Hologic, Inc. regarding conflicts with oral argument (October 3, 2018). Service: 08/08/2018 by email. [541572] [17-2354] [Matthew Wolf] [Entered: 08/08/2018 03:55 PM] (1) |
| Aug 8, 2018 | 84 | Notice from Appellees Abbott Laboratories and Abbott Molecular, Inc. regarding conflicts with oral argument ([update from 6/15/2018 letter]: request not to schedule oral argument October 4 or 5, or during the same week as Nos. 17-1240 and 18-1054 (companion cases), 17-2247, or 17-2348.). Service: 08/08/2018 by email. [541540] [17-2354] [John O'Quinn] [Entered: 08/08/2018 02:14 PM] (3) |
| Jun 15, 2018 | 83 | Notice from Appellees Abbott Laboratories and Abbott Molecular, Inc. regarding conflicts with oral argument ([update from 5/11/2018 letter]: request not to schedule oral argument during the same week as no. 17-1240 and 18-1054 (companions), 17-2490, 17-2247, or 17-2348). Service: 06/15/2018 by email. [529930] [17-2354] [John O'Quinn] [Entered: 06/15/2018 02:50 PM] (2) |
| May 14, 2018 | 82 | 6 paper copies of the Confidential Joint Appendix in 6 Volumes [77] received from Appellant Enzo Life Sciences, Inc.. [521379] [CJF] [Entered: 05/14/2018 12:48 PM] (0) |
| May 11, 2018 | 81 | Notice from Appellees Abbott Laboratories and Abbott Molecular, Inc. regarding conflicts with oral argument (Request not to schedule argument during the July 9-13, 2018 argument week, or during the same argument week as No. 17-2490, 17-2247, or 17-2348). Service: 05/11/2018 by email. [521111] [17-2354] [John O'Quinn] [Entered: 05/11/2018 02:33 PM] (2) |
| May 9, 2018 | 80 | Notice from Appellees Gen-Probe Incorporated and Hologic, Inc. regarding conflicts with oral argument (June 4-5, 2018 and July 12-13, 2018). Service: 05/09/2018 by email. [520348] [17-2354] [Matthew Wolf] [Entered: 05/09/2018 01:03 PM] (2) |
| May 7, 2018 | 79 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 05/14/2018. [519538] [JB] [Entered: 05/07/2018 10:31 AM] (0) |
| May 4, 2018 | 76 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Gen-Probe Incorporated and Hologic, Inc.. Service: 05/04/2018 by email. [519206] [17-2354] [Wallace Wu] [Entered: 05/04/2018 11:59 AM] (2) |
| May 3, 2018 | 78 | APPENDIX FILED for Enzo Life Sciences, Inc. [67], [66]. Number of Pages: 2979. Service: 05/03/2018 by email. Paper copies should be provided of the confidential version only. [519535] [JB] [Entered: 05/07/2018 10:28 AM] (2979) |
| May 3, 2018 | 77 | CONFIDENTIAL JOINT APPENDIX FILED for Enzo Life Sciences, Inc. [65], [64]. Number of Pages: 3629. Service: 05/03/2018 by email. The paper copies of the brief should be received by the court on or before 05/14/2018. [519529] [JB] [Entered: 05/07/2018 10:15 AM] (0) |
| May 3, 2018 | 75 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Becton Dickinson and Company, Becton Dickinson Diagnostics Inc., GeneOhm Sciences Inc., Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., Roche Molecular Systems, Inc. and Roche NimbleGen, Inc.. Service: 05/03/2018 by email. [519023] [17-2354] [Omar Khan] [Entered: 05/03/2018 06:41 PM] (6) |
| May 3, 2018 | 74 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Abbott Laboratories and Abbott Molecular, Inc.. Service: 05/03/2018 by email. [519013] [17-2354] [Jason Wilcox] [Entered: 05/03/2018 06:01 PM] (3) |
| May 3, 2018 | 73 | Notice from Appellant Enzo Life Sciences, Inc. regarding conflicts with oral argument (June 6-8, August 6-10, October 1-5). Service: 05/03/2018 by email. [518939] [17-2354] [Peter Magic] [Entered: 05/03/2018 04:02 PM] (4) |
| May 3, 2018 | 72 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellant Enzo Life Sciences, Inc. and Appellees Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., Roche Molecular Systems, Inc. and Roche NimbleGen, Inc.. Service: 05/03/2018 by email. [518934] [17-2354] [Peter Magic] [Entered: 05/03/2018 03:58 PM] (4) |
| May 3, 2018 | 71 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellant Enzo Life Sciences, Inc. and Appellees Gen-Probe Incorporated and Hologic, Inc.. Service: 05/03/2018 by email. [518933] [17-2354] [Peter Magic] [Entered: 05/03/2018 03:57 PM] (4) |
| May 3, 2018 | 70 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellant Enzo Life Sciences, Inc. and Appellees Becton Dickinson and Company, Becton Dickinson Diagnostics Inc. and GeneOhm Sciences Inc.. Service: 05/03/2018 by email. [518932] [17-2354] [Peter Magic] [Entered: 05/03/2018 03:55 PM] (4) |
| May 3, 2018 | 69 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellant Enzo Life Sciences, Inc. and Appellees Abbott Laboratories and Abbott Molecular, Inc.. Service: 05/03/2018 by email. [518931] [17-2354] [Peter Magic] [Entered: 05/03/2018 03:53 PM] (4) |
| May 3, 2018 | 68 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Enzo Life Sciences, Inc.. Service: 05/03/2018 by email. [518930] [17-2354] [Peter Magic] [Entered: 05/03/2018 03:50 PM] (6) |
| May 3, 2018 | 67 | TENDERED from Appellant Enzo Life Sciences, Inc.. Title: JOINT APPENDIX. Service: 05/03/2018 by email. [518927] [17-2354] [Peter Magic] [Entered: 05/03/2018 03:46 PM] (1406) |
| May 3, 2018 | 66 | TENDERED from Appellant Enzo Life Sciences, Inc.. Title: JOINT APPENDIX. Service: 05/03/2018 by email. [518917] [17-2354] [Peter Magic] [Entered: 05/03/2018 03:36 PM] (1573) |
| May 3, 2018 | 65 | TENDERED from Appellant Enzo Life Sciences, Inc.. Title: CONFIDENTIAL JOINT APPENDIX Service: 05/03/2018 by email. [518911] [17-2354] [Peter Magic] [Entered: 05/03/2018 03:29 PM] (0) |
| May 3, 2018 | 64 | TENDERED from Appellant Enzo Life Sciences, Inc.. Title: CONFIDENTIAL JOINT APPENDIX Service: 05/03/2018 by email. [518906] [17-2354] [Peter Magic] [Entered: 05/03/2018 03:20 PM] (0) |
| Apr 26, 2018 | 63 | 6 paper copies of the Reply Brief [62] received from Appellant Enzo Life Sciences, Inc. [517072] [JCP] [Entered: 04/26/2018 12:46 PM] (0) |
| Apr 24, 2018 | 61 | ORDER denying as moot motion to waive requirements of brief [59] filed by Appellant Enzo Life Sciences, Inc. Service as of this date by the Clerk of Court. [516348] [JB] [Entered: 04/24/2018 11:30 AM] (2) |
| Apr 20, 2018 | 62 | REPLY BRIEF FILED for Appellant Enzo Life Sciences, Inc. [60]. Number of Pages: 32. Service: 04/20/2018 by email. The paper copies of the brief should be received by the court on or before 05/01/2018. [516350] [JB] [Entered: 04/24/2018 11:35 AM] (41) |
| Apr 20, 2018 | 60 | TENDERED from Appellant Enzo Life Sciences, Inc.. Title: REPLY BRIEF. Service: 04/20/2018 by email. [515746] [17-2354] [Peter Magic] [Entered: 04/20/2018 03:40 PM] (41) |
| Apr 5, 2018 | 59 | MOTION of Appellant Enzo Life Sciences, Inc. to waive the requirements regarding the brief (waiver of the word limit for Appellant's Reply Brief under Federal Circuit Rule 32(a) to allow up to 10,000 total words). Any response is due within 10 days of service. [Consent: unopposed]. Service: 04/05/2018 by email. [511083] [17-2354] [Peter Magic] [Entered: 04/05/2018 08:09 PM] (12) |
| Mar 20, 2018 | 58 | 6 paper copies of the Confidential Opening Response Brief [54] received from Appellees Becton Dickinson Diagnostics Inc., Becton Dickinson and Company, Gen-Probe Incorporated, GeneOhm Sciences Inc., Hologic, Inc., Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., Roche Molecular Systems, Inc. and Roche NimbleGen, Inc. [507007] [JCP] [Entered: 03/22/2018 07:50 AM] (0) |
| Mar 16, 2018 | 57 | 6 paper copies of the Opening Response Brief [53] received from Appellees Abbott Laboratories and Abbott Molecular, Inc. [506113] [SJL] [Entered: 03/19/2018 10:03 AM] (0) |
| Mar 12, 2018 | 56 | **TEXT ONLY** ORDER granting motion to extend time to file reply brief [52] filed by Appellant Enzo Life Sciences, Inc. Reply brief is due 04/20/2018.; granting motion to extend time to file appendix [52] filed by Appellant Enzo Life Sciences, Inc. Appendix is due 05/04/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [504241] [JB] [Entered: 03/12/2018 02:49 PM] (0) |
| Mar 12, 2018 | 52 | MOTION of Appellant Enzo Life Sciences, Inc. to extend the time to 04/20/2018 at 11:59 pm to file the reply brief. Any response is due within 10 days of service, to extend the time to 05/04/2018 at 11:59 pm to (inclusive of the requested 28-day extension of time to file reply brief on 4/20/2018) to file the appendix. Any response is due within 10 days of service [Consent: unopposed]. Service: 03/12/2018 by email. [504170] [Peter Magic] [Entered: 03/12/2018 12:49 PM] (12) |
| Mar 9, 2018 | 50 | TENDERED from Appellees Becton Dickinson Diagnostics Inc., Becton Dickinson and Company, Gen-Probe Incorporated, GeneOhm Sciences Inc., Hologic, Inc., Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., Roche Molecular Systems, Inc. and Roche NimbleGen, Inc.. Title: CONFIDENTIAL RESPONSE BRIEF Service: 03/09/2018 by email. [504021] [Matthew Wolf] [Entered: 03/09/2018 09:32 PM] (0) |
| Mar 9, 2018 | 49 | TENDERED from Appellees Abbott Laboratories and Abbott Molecular, Inc.. Title: RESPONSE BRIEF. Service: 03/09/2018 by email. [504017] [Jason Wilcox] [Entered: 03/09/2018 07:54 PM] (86) |
| Mar 9, 2018 | 51 | TENDERED from Appellees Becton Dickinson Diagnostics Inc., Becton Dickinson and Company, Gen-Probe Incorporated, GeneOhm Sciences Inc., Hologic, Inc., Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., Roche Molecular Systems, Inc. and Roche NimbleGen, Inc.. Title: RESPONSE BRIEF. Service: 03/09/2018 by email. [504022] [Matthew Wolf] [Entered: 03/09/2018 09:37 PM] (79) |
| Mar 9, 2018 | 53 | BRIEF FILED for Appellees Abbott Laboratories and Abbott Molecular, Inc. [49]. Number of Pages: 75. Service: 03/09/2018 by email. The paper copies of the brief should be received by the court on or before 03/20/2018. [504232] [JB] [Entered: 03/12/2018 02:30 PM] (86) |
| Mar 9, 2018 | 54 | CONFIDENTIAL BRIEF FILED for Appellees Becton Dickinson Diagnostics Inc., Becton Dickinson and Company, Gen-Probe Incorporated, GeneOhm Sciences Inc., Hologic, Inc., Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., Roche Molecular Systems, Inc. and Roche NimbleGen, Inc. [50]. Number of Pages: 66. Service: 03/09/2018 by email. The paper copies of the brief should be received by the court on or before 03/20/2018. [504235] [JB] [Entered: 03/12/2018 02:37 PM] (0) |
| Mar 9, 2018 | 55 | BRIEF FILED for Appellees Becton Dickinson Diagnostics Inc., Becton Dickinson and Company, Gen-Probe Incorporated, GeneOhm Sciences Inc., Hologic, Inc., Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., Roche Molecular Systems, Inc. and Roche NimbleGen, Inc. [51]. Number of Pages: 66. Service: 03/09/2018 by email. Appellant Enzo Life Sciences, Inc. reply brief is due 03/23/2018. Paper copies should be provided of the confidential version only. [504237] [JB] [Entered: 03/12/2018 02:42 PM] (79) |
| Jan 2, 2018 | 48 | Entry of appearance for Anuradha Sivaram as of counsel for Appellees Becton Dickinson Diagnostics Inc., Becton Dickinson and Company, GeneOhm Sciences Inc., Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., Roche Molecular Systems, Inc. and Roche NimbleGen, Inc.. Service: 01/02/2018 by email. [486593] [Anuradha Sivaram] [Entered: 01/02/2018 12:12 PM] (2) |
| Dec 6, 2017 | 47 | **TEXT ONLY** ORDER granting motion to extend time to file appellees principal brief [46] filed by Appellees Abbott Laboratories, Abbott Molecular, Inc., Becton Dickinson Diagnostics Inc., Becton Dickinson and Company, Gen-Probe Incorporated, GeneOhm Sciences Inc., Hologic, Inc., Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., Roche Molecular Systems, Inc. and Roche NimbleGen, Inc. Appellees brief is due 03/09/2018. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [480487] [JB] [Entered: 12/06/2017 09:21 AM] (0) |
| Dec 5, 2017 | 46 | MOTION of Appellees Abbott Laboratories, Abbott Molecular, Inc., Becton Dickinson Diagnostics Inc., Becton Dickinson and Company, Gen-Probe Incorporated, GeneOhm Sciences Inc., Hologic, Inc., Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., Roche Molecular Systems, Inc. and Roche NimbleGen, Inc. to extend the time to 03/09/2018 to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 12/05/2017 by email. [480415] [Wallace Wu] [Entered: 12/05/2017 04:33 PM] (20) |
| Dec 1, 2017 | 45 | 6 paper copies of the Opening Brief [44] received from Appellant Enzo Life Sciences, Inc. [479579] [CW] [Entered: 12/01/2017 11:50 AM] (0) |
| Nov 28, 2017 | 44 | BRIEF FILED for Appellant Enzo Life Sciences, Inc. [43]. Number of Pages: 64. Service: 11/28/2017 by email. The paper copies of the brief should be received by the court on or before 12/06/2017. Appellees Abbott Laboratories, Abbott Molecular, Inc., Becton Dickinson Diagnostics Inc., Becton Dickinson and Company, Gen-Probe Incorporated, GeneOhm Sciences Inc., Hologic, Inc., Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., Roche Molecular Systems, Inc. and Roche NimbleGen, Inc. brief is due 01/08/2018. [479043] [CMP] [Entered: 11/29/2017 04:11 PM] (295) |
| Nov 28, 2017 | 43 | TENDERED from Appellant Enzo Life Sciences, Inc.. Title: OPENING BRIEF. Service: 11/28/2017 by email. [478634] [Peter Magic] [Entered: 11/28/2017 01:36 PM] (295) |
| Sep 29, 2017 | 42 | Docketing Statement for the Appellees Abbott Laboratories and Abbott Molecular, Inc.. Service: 09/29/2017 by email. [464523] [Jason Wilcox] [Entered: 09/29/2017 07:07 PM] (4) |
| Sep 29, 2017 | 41 | Certificate of Interest for the Appellees Abbott Laboratories and Abbott Molecular, Inc.. Service: 09/29/2017 by email. [464522] [Jason Wilcox] [Entered: 09/29/2017 07:06 PM] (3) |
| Sep 29, 2017 | 40 | Entry of appearance for Michael A. Pearson, Jr. as of counsel for Appellees Abbott Laboratories and Abbott Molecular, Inc.. Service: 09/29/2017 by email. [464521] [Jason Wilcox] [Entered: 09/29/2017 07:04 PM] (2) |
| Sep 29, 2017 | 39 | Entry of appearance for Benjamin A. Lasky as of counsel for Appellees Abbott Laboratories and Abbott Molecular, Inc.. Service: 09/29/2017 by email. [464520] [Jason Wilcox] [Entered: 09/29/2017 07:03 PM] (2) |
| Sep 29, 2017 | 38 | Entry of appearance for Amanda Hollis as of counsel for Appellees Abbott Laboratories and Abbott Molecular, Inc.. Service: 09/29/2017 by email. [464519] [Jason Wilcox] [Entered: 09/29/2017 07:02 PM] (2) |
| Sep 29, 2017 | 37 | Entry of appearance for James F. Hurst as principal counsel for Appellees Abbott Laboratories and Abbott Molecular, Inc.. Service: 09/29/2017 by email. [464518] [Jason Wilcox] [Entered: 09/29/2017 07:01 PM] (2) |
| Sep 29, 2017 | 36 | Entry of appearance for John C. O'Quinn as of counsel for Appellees Abbott Laboratories and Abbott Molecular, Inc.. Service: 09/29/2017 by email. [464517] [Jason Wilcox] [Entered: 09/29/2017 07:00 PM] (2) |
| Sep 29, 2017 | 35 | Entry of appearance for Jason M. Wilcox as of counsel for Appellees Abbott Laboratories and Abbott Molecular, Inc.. Service: 09/29/2017 by email. [464516] [Jason Wilcox] [Entered: 09/29/2017 06:58 PM] (2) |
| Sep 29, 2017 | 34 | Amended Docketing Statement for the Appellant Enzo Life Sciences, Inc.. Service: 09/29/2017 by email. [464515] [Peter Magic] [Entered: 09/29/2017 06:51 PM] (6) |
| Sep 29, 2017 | 33 | Amended Certificate of Interest for the Appellant Enzo Life Sciences, Inc.. Service: 09/29/2017 by email. [464514] [Peter Magic] [Entered: 09/29/2017 06:48 PM] (2) |
| Sep 29, 2017 | 32 | Amended Entry of appearance for Peter C. Magic as of counsel for Appellant Enzo Life Sciences, Inc.. Service: 09/29/2017 by email. [464513] [Peter Magic] [Entered: 09/29/2017 06:46 PM] (2) |
| Sep 29, 2017 | 31 | Amended Entry of appearance for Justin P.D. Wilcox as of counsel for Appellant Enzo Life Sciences, Inc.. Service: 09/29/2017 by email. [464512] [Justin Wilcox] [Entered: 09/29/2017 06:43 PM] (2) |
| Sep 29, 2017 | 30 | Amended Entry of appearance for John M. Desmarais as of counsel for Appellant Enzo Life Sciences, Inc.. Service: 09/29/2017 by email. [464509] [John Desmarais] [Entered: 09/29/2017 06:39 PM] (2) |
| Sep 29, 2017 | 29 | Amended Entry of appearance for Michael P. Stadnick as principal counsel for Appellant Enzo Life Sciences, Inc.. Service: 09/29/2017 by email. [464507] [Michael Stadnick] [Entered: 09/29/2017 06:34 PM] (2) |
| Sep 15, 2017 | 28 | Official caption revised to add defendants-appellees for consolidated cases docketed on 9/15/2017. Entry of Appearance due 09/29/2017. Certificate of Interest is due on 09/29/2017. Docketing Statement due 09/29/2017. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by Clerk of Court. [461284] [JB] [Entered: 09/15/2017 12:21 PM] (0) |
| Sep 15, 2017 | 27 | Note to file: The following cases are associated: 17-2354 (Lead) with 17-2545 and 17-2546 (Consolidated). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [461269] [JB] [Entered: 09/15/2017 12:13 PM] (0) |
| Sep 12, 2017 | 26 | Docketing Statement for the Appellees Becton Dickinson Diagnostics Inc., Becton Dickinson and Company, GeneOhm Sciences Inc., Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., Roche Molecular Systems, Inc. and Roche NimbleGen, Inc.. Service: 09/12/2017 by email. [460536] [Omar Khan] [Entered: 09/12/2017 06:04 PM] (4) |
| Sep 12, 2017 | 25 | Certificate of Interest for the Appellees Becton Dickinson Diagnostics Inc., Becton Dickinson and Company, GeneOhm Sciences Inc., Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., Roche Molecular Systems, Inc. and Roche NimbleGen, Inc.. Service: 09/12/2017 by email. [460535] [Omar Khan] [Entered: 09/12/2017 06:02 PM] (4) |
| Sep 12, 2017 | 24 | Entry of appearance for Christopher R. Noyes as of counsel for Appellees Becton Dickinson Diagnostics Inc., Becton Dickinson and Company, GeneOhm Sciences Inc., Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., Roche Molecular Systems, Inc. and Roche NimbleGen, Inc.. Service: 09/12/2017 by email. [460534] [Christopher Noyes] [Entered: 09/12/2017 06:01 PM] (2) |
| Sep 12, 2017 | 23 | Entry of appearance for Thomas G. Saunders as of counsel for Appellees Becton Dickinson Diagnostics Inc., Becton Dickinson and Company, GeneOhm Sciences Inc., Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., Roche Molecular Systems, Inc. and Roche NimbleGen, Inc.. Service: 09/12/2017 by email. [460533] [Thomas Saunders] [Entered: 09/12/2017 05:59 PM] (2) |
| Sep 12, 2017 | 22 | Entry of appearance for William G. McElwain as of counsel for Appellees Becton Dickinson Diagnostics Inc., Becton Dickinson and Company, GeneOhm Sciences Inc., Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., Roche Molecular Systems, Inc. and Roche NimbleGen, Inc.. Service: 09/12/2017 by email. [460532] [William McElwain] [Entered: 09/12/2017 05:56 PM] (2) |
| Sep 12, 2017 | 21 | Entry of appearance for Robert J. Gunther, Jr. as of counsel for Appellees Becton Dickinson Diagnostics Inc., Becton Dickinson and Company, GeneOhm Sciences Inc., Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., Roche Molecular Systems, Inc. and Roche NimbleGen, Inc.. Service: 09/12/2017 by email. [460531] [Robert Gunther] [Entered: 09/12/2017 05:54 PM] (2) |
| Sep 12, 2017 | 20 | Entry of appearance for Omar Khan as principal counsel for Appellees Becton Dickinson Diagnostics Inc., Becton Dickinson and Company, GeneOhm Sciences Inc., Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., Roche Molecular Systems, Inc. and Roche NimbleGen, Inc.. Service: 09/12/2017 by email. [460530] [Omar Khan] [Entered: 09/12/2017 05:51 PM] (2) |
| Sep 12, 2017 | 19 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a)and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [460372] [JB] [Entered: 09/12/2017 12:03 PM] (0) |
| Sep 8, 2017 | 18 | Note to file: The following cases are consolidated: 17-2354 (Lead) with 17-2498 and 17-2499 (Consolidated). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [459642] [JB] [Entered: 09/08/2017 10:44 AM] (0) |
| Sep 8, 2017 | 17 | ORDER consolidating appeals (17-2354 (Lead) with 17-2498 and 17-2499 (Consolidated)). The appeals are consolidated. The revised official caption is reflected above. Enzo Life Sciences, Inc.'s opening brief is due no later than November 28, 2017. Service as of this date by Clerk of Court. [459641] [JB] [Entered: 09/08/2017 10:41 AM] (2) |
| Sep 7, 2017 | 16 | **TEXT ONLY** ORDER granting motion to extend time to file appellant's principal brief [15] filed by Appellant Enzo Life Sciences, Inc. Brief is due on 11/28/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [459201] [JB] [Entered: 09/07/2017 09:39 AM] (0) |
| Sep 6, 2017 | 15 | MOTION of Appellant Enzo Life Sciences, Inc. to extend the time to 11/28/2017 at 11:59 pm to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 09/06/2017 by email. [459134] [Peter Magic] [Entered: 09/06/2017 09:08 PM] (8) |
| Aug 14, 2017 | 14 | Entry of appearance for Jennifer A. Sklenar as of counsel for Appellees Gen-Probe Incorporated and Hologic, Inc.. Service: 08/14/2017 by email. [453912] [Jennifer Sklenar] [Entered: 08/14/2017 10:35 PM] (2) |
| Aug 14, 2017 | 13 | Entry of appearance for Wallace Wu as of counsel for Appellees Gen-Probe Incorporated and Hologic, Inc.. Service: 08/14/2017 by email. [453911] [Wallace Wu] [Entered: 08/14/2017 10:30 PM] (2) |
| Aug 14, 2017 | 12 | Entry of appearance for Matthew M. Wolf as principal counsel for Appellees Gen-Probe Incorporated and Hologic, Inc.. Service: 08/14/2017 by email. [453910] [Matthew Wolf] [Entered: 08/14/2017 10:23 PM] (2) |
| Aug 14, 2017 | 11 | Certificate of Interest for the Appellees Gen-Probe Incorporated and Hologic, Inc.. Service: 08/14/2017 by email. [453909] [Matthew Wolf] [Entered: 08/14/2017 10:21 PM] (3) |
| Aug 14, 2017 | 10 | Docketing Statement for the Appellees Gen-Probe Incorporated and Hologic, Inc.. Service: 08/14/2017 by email. [453908] [Matthew Wolf] [Entered: 08/14/2017 10:19 PM] (3) |
| Aug 14, 2017 | 9 | Docketing Statement for the Appellant Enzo Life Sciences, Inc.. Service: 08/14/2017 by email. [453852] [Peter Magic] [Entered: 08/14/2017 04:54 PM] (3) |
| Aug 14, 2017 | 8 | Certificate of Interest for the Appellant Enzo Life Sciences, Inc.. Service: 08/14/2017 by email. [453849] [Peter Magic] [Entered: 08/14/2017 04:50 PM] (2) |
| Aug 14, 2017 | 7 | Entry of appearance for Peter C. Magic as of counsel for Appellant Enzo Life Sciences, Inc.. Service: 08/14/2017 by email. [453848] [Peter Magic] [Entered: 08/14/2017 04:46 PM] (2) |
| Aug 14, 2017 | 6 | Entry of appearance for Justin P.D. Wilcox as of counsel for Appellant Enzo Life Sciences, Inc.. Service: 08/14/2017 by email. [453846] [Justin Wilcox] [Entered: 08/14/2017 04:41 PM] (2) |
| Aug 14, 2017 | 5 | Entry of appearance for John M. Desmarais as of counsel for Appellant Enzo Life Sciences, Inc.. Service: 08/14/2017 by email. [453842] [John Desmarais] [Entered: 08/14/2017 04:33 PM] (2) |
| Aug 14, 2017 | 4 | Entry of appearance for Michael P. Stadnick as principal counsel for Appellant Enzo Life Sciences, Inc.. Service: 08/14/2017 by email. [453831] [Michael Stadnick] [Entered: 08/14/2017 04:26 PM] (2) |
| Aug 3, 2017 | 3 | Note to file: The following cases are associated:17-2354 Lead with 17-2355 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [451341] [17-2354, 17-2355] [JB] [Entered: 08/03/2017 04:07 PM] (0) |
| Aug 2, 2017 | 2 | ORDER consolidating appeals (17-2354 Lead with 17-2355 Consolidated). Enzo Life Sciences, Inc.s opening brief is due no later than September 29, 2017. Service as of this date by Clerk of Court. [451335] [JB] [Entered: 08/03/2017 04:04 PM] (2) |
| Jul 31, 2017 | 1 | Appeal docketed. Received: 07/28/2017. [450269]Entry of Appearance due 08/14/2017. Certificate of Interest is due on 08/14/2017. Docketing Statement due 08/14/2017. Appellant/Petitioner's brief is due 09/29/2017. [JB] [Entered: 07/31/2017 09:12 AM] (103) |
